Risk profiling of patients (pts) with previously untreated Diffuse Large B-Cell Lymphoma (DLBCL) by measuring circulating tumor DNA (ctDNA): 3-year update of the POLARIX studyT. Oellerich,G. Lenz,A. F. Herrera,R. McCord,P. Kimes,F. Jardin,M. Trneny,C. R. Flowers,L. H. Sehn,G. Salles,J. P. Sharman,H. Tilly,J. W. Friedberg,C. Herbaux,M. Matasar,C. Haioun,S. Tracy,J. Hirata,C. Lee,Y. Jiang,F. MorschhauserBlood(2023)引用 2|浏览27暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要